Low trauma wound dressing with improved moisture vapor permeability

Claim 2

A low trauma wound dressing having improved moisture vapor permeability comprising layers of (i) a moisture-vapor permeable backing, and (ii) a contiguous particulate adhesive layer of tacky, substantially solvent-insoluble, solvent-dispersible, acrylate-based, elastomeric, pressure-sensitive adhesive microspheres, wherein the adhesive layer further comprises an antimicrobial system effective for achieving a reduction in surface bacteria which includes at least an antimicrobial agent and a transfer agent.

Claim 3

The wound dressing of claim 1 wherein the antimicrobial agent is chlorhexidine.

Claim 4

The wound dressing of claim 2 wherein the transfer agent is glycerin.

Claim 5

The wound dressing of claim 1 wherein the adhesive layer is effective for achieving at least a 2.5 log reduction in surface bacteria.

Claim 6

The wound dressing of claim 1 wherein a majority of the adhesive microspheres contain at least one interior void having a diameter of at least about 10% of the diameter of the microsphere.

Claim 7

The wound dressing of claim 1 wherein a majority of the adhesive microspheres contain at least one substantially spherical interior void having a diameter of at least about 30% of the diameter of the microsphere.

Claim 8

The wound dressing of claim 1 wherein the adhesive microspheres have an average diameter of at least 1 micrometer.

Claim 9

The wound dressing of claim 1 wherein the adhesive microspheres are formed from an acrylate polymer having a glass transition temperature of less than about -20° C.

Claim 10

The wound dressing of claim 1 wherein the adhesive microspheres are comprised of at least one alkyl acrylate or alkyl methacrylate ester selected from the group consisting of n-butyl acrylate, sec-butyl acrylate, 2-methyl butyl acrylate, 4-methyl-2-penthyl acrylate, 2-ethyl hexyl acrylate, isooctyl acrylate, isononyl acrylate, isoamyl acrylate, isodecyl acrylate, and isodecyl methacrylate.

Claim 11

The wound dressing of claim 1 wherein the adhesive microspheres include (a) at least about 75 wt % of at least one alkyl acrylate or alkyl methacrylate ester, and (b) a balance of at least one polar monomer.

Claim 12

The wound dressing of claim 10 wherein the alkyl acrylate is selected from the group consisting of (a) an acrylate or methacrylate ester of a non-tertiary C 4-12 alcohol, and (b) an acrylate or methacrylate ester of a mixture of non-tertiary C 1-14 alcohols with a resultant average of between about 4-12 carbon atoms per alcohol molecule.

Claim 13

The wound dressing of claim 10 wherein the polar monomer is selected from the group consisting of acrylic acid, methacrylic acid, itaconic acid, crotonic acid, maleic acid, fumaric acid, and salts thereof.

Claim 14

The wound dressing of claim 1 wherein the adhesive microspheres include (a) at least about 75 wt % of at least one alkyl acrylate or alkyl methacrylate ester, and (b) up to 25 wt % of a combination of (A) a polar monomer selected from the group consisting of acrylic acid, methacrylic acid, itaconic acid, crotonic acid, maleic acid, fumaric acid, and salts thereof, (B) a hydrophilic N-vinyllactam, and (C) a hydrophilic alkylene oxide acrylate having an average of about 3 to 40 alkylene oxide units.

Claim 15

The wound dressing of claim 1 wherein the adhesive comprises: (a) about 70 to 90 wt % microspheres, and (b) about 10 to 30 wt % binder copolymer comprising an elastomeric polymeric backbone having pendant polymeric moieties with the backbone comprised of: (A) about 50 to 98 wt % of a first monomer comprising an acrylate or methacrylate ester of a non-tertiary C 4-12 alcohol or an acrylate or methacrylate ester of a mixture of non-tertiary C 1-14 alcohols with a resultant average of between about 4-12 carbon atoms per alcohol molecule, (B) about 1 to 20 wt % of a second polar monomer copolymerizable with the first monomer, and (C) about 0 to 30 wt % of a third monomer having the general formula X-(Y) n -Z where (1) X is a vinyl group copolymerizable with monomers A and B, (2) Y is a divalent linking group, (3) n is 0 or 1, and (4) Z is a monovalent polymeric moiety having a glass transition temperature of greater than 20° C. with a molecular weight of about 2,000 to about 30,000 and being essentially unreactive under copolymerization conditions.

Claim 16

The wound dressing of claim 14 wherein the adhesive microspheres further include at least one polar monomer.

Claim 17

The wound dressing of claim 1 wherein the microspheres comprise (a) at least about 85 wt % of an alkyl acrylate ester selected from the group consisting of n-butyl acrylate, sec-butyl acrylate, 2-methyl butyl acrylate, 4-methyl-2-pentyl acrylate, 2-ethyl hexyl acrylate, isooctyl acrylate, isononyl acrylate, isoamyl acrylate, isodecyl acrylate, and isodecyl methacrylate, and (b) up to 15 wt % of at least one polar monomer selected from the group consisting of acrylic acid, methacrylic acid, itaconic acid, crotonic acid, maleic acid, fumaric acid, and salts thereof.

Claim 18

The wound dressing of claim 15 wherein the second monomer is selected from the group consisting of acrylic acid, methacrylic acid, itaconic acid, N-vinylpyrrolidone, acrylamide, methacrylamide, acrylonitrile and methacrylonitrile.

Claim 19

The wound dressing of claim 15 wherein a majority of the adhesive microspheres contain at least one substantially spherical interior void having a diameter of at least about 10% of the diameter of the microsphere.

Claim 20

The wound dressing of claim 8 wherein (a) the adhesive microspheres are formed from non-ionic monomers and comprise a major portion of at least one oleophilic, water-emulsifiable alkyl acrylate or methacrylate ester.

Claim 21

The wound dressing of claim 1 wherein (a) the adhesive microspheres consist essentially of: (A) about 90 to about 99.5 wt % of one or more oleophilic, water-emulsifiable alkyl acrylate esters, at lease one of said esters being selected from the group consisting of isooctyl acrylate, 4-methyl-2-penthyl acrylate, 2-methylbutyl acrylate, sec-butyl acrylate, n-butyl acrylate and 2-ethyl hexyl acrylate, and (B) about 10 to about 0.5 percent by weight of one or more additional monomers selected from the group consisting of a trimethylamine methacrylimide, trimethylamine p-vinylbenzimide, ammonium acrylate, sodium acrylate, N,N-dimethyl-N-(β-methacryloxyethyl) ammonium propionate betaine, 1,1-dimethyl-1-(2,3-dihydroxypropyl) amine methacrylimide, 4,4,9-trimethyl-4-azonia-7-oxo-8-oxa-9-decene-1-sulphonate, 1,1-dimethyl-1-(2,3-dihydroxypropyl) amine methacrylimide, and maleic anhydride; and (b) the adhesive microspheres are prepared by aqueous suspension polymerization in the presence of a suitable emulsifier at a level above said emulsifier's critical micelle concentration.

Claim 22

The wound dressing of claim 20 wherein the adhesive microspheres consist essentially of about 98 to about 99.5 wt % alkyl acrylate esters and 0.5 to 2 wt % additional monomers.

Claim 23

The wound dressing of claim 1 wherein the backing is polyurethane.

Claim 24

The wound dressing of claim 22 wherein the backing is transparent polyurethane having a MVTR up of at least 500 g/m 2 .

Claim 25

A low trauma wound dressing having improved moisture vapor permeability comprising laminated layers of a moisture-vapor permeable backing and a multiple stratum adhesive layer of tacky, substantially solvent-insoluble, solvent-dispersible, acrylate-based, elastomeric, pressure-sensitive adhesive microspheres wherein at least an outermost stratum of the adhesive layers further comprises an antimicrobial system which includes at least an antimicrobial agent and a transfer agent.

Claim 26

A low trauma wound dressing having improved moisture vapor permeability comprising laminated layers of a moisture-vapor permeable backing and a multiple stratum adhesive layer of tacky, substantially solvent-insoluble, solvent-dispersible, acrylate-based, elastomeric, pressure-sensitive adhesive microspheres wherein at least an outermost stratum of the adhesive layers further comprises an antimicrobial system which includes at least an antimicrobial agent and a transfer agent.

Claim 27

The wound dressing of claim 24 wherein a majority of the adhesive microspheres contain at least one interior void having a diameter of at least about 10% of the diameter of the microsphere.

Claim 28

The wound dressing of claim 24 wherein the adhesive microspheres include (a) at least about 75 wt % of at least one alkyl acrylate or alkyl methacrylate ester, and (b) up to 25 wt % of a combination of (A) a polar monomer selected from the group consisting of acrylic acid, methacrylic acid, itaconic acid, crotonic acid, maleic acid, fumaric acid, and salts thereof, (B) a hydrophilic N-vinyllactam, and (C) a hydrophilic alkylene oxide acrylate having an average of about 3 to 40 alkylene oxide units.

Claim 29

The wound dressing of claim 24 wherein the adhesive comprises: (a) about 70 to 99 wt % microspheres, and (b) about 1 to 30 wt % binder copolymer comprising an elastomeric polymeric backbone having pendant polymeric moieties with the backbone comprised of: (A) about 50 to 98 wt % of a first monomer comprising an acrylate or methacrylate ester of a non-tertiary C 4-12 alcohol or an acrylate or methacrylate ester of a mixture of non-tertiary C 1-14 alcohols with a resultant average of between about 4-12 carbon atoms per alcohol molecule, (B) about 1 to 20 wt % of a second polar monomer copolymerizable with the first monomer, and (C) about 1 to 30 wt % of a third monomer having the general formula X-(Y) n -Z where (1) X is a vinyl group copolymerizable with monomers A and B, (2) Y is a divalent linking group, (3) n is 0 or 1, and (4) Z is a monovalent polymeric moiety having a glass transition temperature of greater than 20° C. with a molecular weight of about 2,000 to about 30,000 and being essentially unreactive under copolymerization conditions.

Claim 30

The wound dressing of claim 24 wherein (a) the adhesive microspheres are formed from non-ionic monomers and comprise a major portion of at least one oleophilic, water-emulsifiable alkyl acrylate or methacrylate ester, and (b) the adhesive microspheres are prepared by aqueous suspension polymerization in the presence of at least one suitable emulsifier at a concentration level above the emulsifier's critical micelle concentration and a suitable polymeric suspension stabilizer.

Claim 31

The wound dressing of claim 24 wherein the backing is polyurethane.

Claim 32

A low trauma wound dressing having improved moisture vapor permeability comprising layers of (i) a moisture-vapor permeable backing, and (ii) a particulate adhesive layer containing at least (a) a major amount of a tacky, substantially solvent-insoluble, solvent-dispersible, acrylate-based, elastomeric, pressure-sensitive adhesive microspheres, (b) a minor amount of a binder, and (c) a combination of an antimicrobial agent and a transfer agent effective for achieving a reduction in surface bacteria.

Claim 33

A low trauma wound dressing having improved moisture vapor permeability comprising layers of (i) a moisture-vapor permeable backing, and (ii) a particulate adhesive layer containing at least (a) a major amount of a tacky, substantially solvent-insoluble, solvent-dispersible, acrylate-based, elastomeric, pressure-sensitive adhesive microspheres, (b) a minor amount of a binder, and (c) a combination of an antimicrobial agent and a transfer agent effective for achieving a reduction in surface bacteria.

Claim 34

The wound dressing of claim 30 wherein the backing is transparent polyurethane having a MVTR up of at least 500 g/m 2 .

Claim 35

The wound dressing of claim 30 wherein the adhesive microspheres have an average diameter of at least 1 micrometer.

Claim 36

The wound dressing of claim 30 wherein the adhesive microspheres are formed from an acrylate polymer having a glass transition temperature of less than about -20° C.

Claim 37

The wound dressing of claim 30 wherein the adhesive microspheres are comprised of at least one alkyl acrylate or alkyl methacrylate ester selected from the group consisting of n-butyl acrylate, sec-butyl acrylate, 2-methyl butyl acrylate, 4-methyl-2-pentyl acrylate, 2-ethyl hexyl acrylate, isooctyl acrylate, isononyl acrylate, isoamyl acrylate, isodecyl acrylate, and isodecyl methacrylate.

Claim 38

The wound dressing of claim 30 wherein the adhesive microspheres include (a) at least about 75 wt % of at least one alkyl acrylate or alkyl methacrylate ester, and (b) a balance of at least one polar monomer.

Claim 39

The wound dressing of claim 35 wherein the alkyl acrylate is selected from the group consisting of (a) an acrylate or methacrylate ester of a non-tertiary C 4-12 alcohol, and (b) an acrylate or methacrylate ester of a mixture of non-tertiary C 1-14 alcohols with a resultant average of between about 4-12 carbon atoms per alcohol molecule.

Claim 40

The wound dressing of claim 35 wherein the polar monomer is selected from the group consisting of acrylic acid, methacrylic acid, itaconic acid, crotonic acid, maleic acid, fumaric acid, and salts thereof.

Claim 41

The wound dressing of claim 30 wherein the adhesive microspheres include (a) at least about 75 wt % of at least one alkyl acrylate or alkyl methacrylate ester, and (b) up to 25 wt % of a combination of (A) a polar monomer selected from the group consisting of acrylic acid, methacrylic acid, itaconic acid, crotonic acid, maleic acid, fumaric acid, and salts thereof, (B) a hydrophilic N-vinyllactam, and (C) a hydrophilic alkylene oxide acrylate having an average of about 3 to 40 alkylene oxide units.

Claim 42

The wound dressing of claim 30 wherein: (a) the adhesive microspheres consist essentially of: (i) about 90 to about 99.5 wt % of one or more oleophilic, water-emulsifiable alkyl acrylate esters, at least one of said esters being selected from the group consisting of isooctyl acrylate, 4-methyl-2-pentyl acrylate, 2methylbutyl acrylate, sec-butyl acrylate, n-butyl acrylate and 2-ethyl hexyl acrylate, and (ii) about 10 to about 0.5 percent by weight of one or more additional monomers selected from the group consisting of trimethylamine methacrylimide, trimethylamine p-vinylbenzimide, ammonium acrylate, sodium acrylate, N,N-dimethyl-N-(β-methacryloxyethyl) ammonium propionate betaine, 1,1-dimethyl-1-(2,3-dihydroxypropyl) amine methacrylimide, 4,4,9-trimethyl-4-azonia-7-oxo-8-oxa-9-decene-1-sulphonate, 1,1 -dimethyl- 1-(2,3-dihydroxypropyl) amine methacrylimide, and maleic anhydride; and (b) the adhesive microspheres are prepared by aqueous suspension polymerization in the presence of a suitable emulsifier at a level above said emulsifier's critical micelle concentration.

Claim 43

The wound dressing of claim 39 wherein the adhesive microspheres consist essentially of about 98 to about 99.5 wt % alkyl acrylate esters and 0.5 to 2 wt % additional monomers.

Claim 44

The wound dressing of claim 30 wherein the adhesive comprises about 10 to 30 wt % binder with the binder comprising a copolymer having an elastomeric polymeric backbone and pendant polymeric moieties with the backbone comprised of (i) about 50 to 98 wt % of a first monomer comprising an acrylate or methacrylate ester of a non-tertiary C 4-12 alcohol, or an acrylate or methacrylate ester of a mixture of non-tertiary C 1-14 alcohols with a resultant average of between about 4-12 carbon atoms per alcohol molecule, (ii) about 1 to 20 wt % of a polar second monomer copolymerizable with the first monomer, and (iii) about 0 to 30 wt % of a third monomer having the general formula X-(Y) n -Z where (a) X is a vinyl group copolymerizable with monomers (i) and (ii), (b) Y is a divalent linking group, (c) n is 0 or 1, and (d) Z is a monovalent polymeric moiety having a glass transition temperature of greater than 20° C. with a molecular weight of about 2,000 to about 30,000 and being essentially unreactive under copolymerization conditions.

Claim 45

The wound dressing of claim 30 wherein the antimicrobial agent is chlorhexidine.

Claim 46

The wound dressing of claim 42 wherein the transfer agent is glycerin.

Claim 47

The wound dressing of claim 30 wherein the adhesive layer is effective for achieving at least a 5 log reduction in surface bacteria.